Myricx Pharma Ltd

Myricx Pharma Limited, doing business as Myricx Bio, operates as a biotech company. The Company focuses on discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates, based on inhibitors of n-myristoyltransferases for the treatment of cancer. Myricx Bio serves healthcare professionals in the United States and in the United Kingdom.